Alnylam Pharmaceuticals, Inc. (ALNY)

295.91 -13.58 (-4.39%) USD  |  NASDAQ  |  May 01, 16:00
296.18 +0.27 (+0.09%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Pfizer Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Glaukos Corp. Upgrade